(4R,4aS,7S,7aR,12bS)-9-methoxy-3-prop-2-enyl-1,2,4,5,6,7,7a,13-octahydro-4,12-methanobenzofuro[3,2-e]isoquinoline-4a,7-diol | 116388-84-2

• 分子结构分类: 有机化合物 - 苯类化合物 - 菲及其衍生物
• 英文名称: (4R,4aS,7S,7aR,12bS)-9-methoxy-3-prop-2-enyl-1,2,4,5,6,7,7a,13-octahydro-4,12-methanobenzofuro[3,2-e]isoquinoline-4a,7-diol
• CAS: 116388-84-2
• 化学式: C₂₀H₂₅NO₄
• 分子量: 343.423
• InChiKey: CWSZXXDJVDCDEW-LRLHPVAZSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  -0.1
• 重原子数：
  25
• 可旋转键数：
  3
• 环数：
  5.0
• sp3杂化的碳原子比例：
  0.6
• 拓扑面积：
  62.2
• 氢给体数：
  2
• 氢受体数：
  5

反应信息

• 作为反应物：
  描述：

  (4R,4aS,7S,7aR,12bS)-9-methoxy-3-prop-2-enyl-1,2,4,5,6,7,7a,13-octahydro-4,12-methanobenzofuro[3,2-e]isoquinoline-4a,7-diol 在 三溴化硼 作用下， 以 氯仿 为溶剂， 反应 2.0h， 生成 3,6α,14-triacetoxy-17-allyl-4,5α-epoxy-morphinane
  参考文献：
  名称：

  Morphine alkaloids, part 114. A stereohomogeneous synthesis of N-demethyl-N-substituted-14-hydroxydihydromorphines

  摘要：

  A new route for the stereohomogeneous synthesis of N-demethyl-N-substituted-14-hydroxydihydromorphines 2 a - f has been elaborated, involving O-demethylation of the novel dihydrocodeine derivatives 6 a - f, obtained upon alkylation of the hitherto unknown N-demethyl-14-hydroxydihydrocodeine (5).

  DOI：

  10.1007/bf00817599
• 作为产物：
  描述：

  6α,14β-diacetoxy-4,5percenta-epoxy-3-methoxy-17-methyl-morphinan 在 盐酸 、 碳酸氢钠 作用下， 以 乙醇 、 二氯甲烷 、 1,2-二氯乙烷 为溶剂， 反应 21.0h， 生成 (4R,4aS,7S,7aR,12bS)-9-methoxy-3-prop-2-enyl-1,2,4,5,6,7,7a,13-octahydro-4,12-methanobenzofuro[3,2-e]isoquinoline-4a,7-diol
  参考文献：
  名称：

  Morphine alkaloids, part 114. A stereohomogeneous synthesis of N-demethyl-N-substituted-14-hydroxydihydromorphines

  摘要：

  A new route for the stereohomogeneous synthesis of N-demethyl-N-substituted-14-hydroxydihydromorphines 2 a - f has been elaborated, involving O-demethylation of the novel dihydrocodeine derivatives 6 a - f, obtained upon alkylation of the hitherto unknown N-demethyl-14-hydroxydihydrocodeine (5).

  DOI：

  10.1007/bf00817599

文献信息

• (+)-morphinans as antagonists of Toll-like receptor 9 and therapeutic uses thereof
  申请人：Mallinckrodt LLC

  公开号：US11142502B2

  公开（公告）日：2021-10-12

  The present invention provides (+)-morphinans comprising Toll-like receptor 9 (TLR9) antagonist activity, as well as methods for using the (+)-morphinans to treat pain. Also provided are pharmaceutical combination compositions comprising a (+)-morphinan and an opioid agonist/monoamine reuptake inhibitor, as well as methods for using the combination compositions to treat pain.

  本发明提供了包含Toll样受体9（TLR9）拮抗剂活性的(+)-吗啡烷，以及使用(+)-吗啡烷治疗疼痛的方法。本发明还提供了包含(+)-吗啡南和阿片激动剂/单胺再摄取抑制剂的药物组合物，以及使用该组合物治疗疼痛的方法。
• Stereoselective synthesis of β-naltrexol, β-naloxol β-naloxamine, β-naltrexamine and related compounds by the application of the mitsunobu reac
  作者：Csaba Simon、Sándor Hosztafi、Sándor Makleit

  DOI：10.1016/s0040-4020(01)85541-1

  日期：1994.1

  As a continuation of our work, aimed at adopting the Mitsunobu reaction in the morphine series, a few representatives of dihydroisocodeines and dihydroisomorphines and their 14 beta-hydroxy analogues were prepared. p-Nitrobenzoic acid was used as carboxylic acid and the prepared esters were cleaved to obtain the title compounds. Using phthalimide as acidic component several new 6 beta-phthalimidodihydromorphine and dihydrocodeine derivatives and their 14 beta-hydroxy analogues have been synthesized. Cleavage of the phthalimido derivatives with hydrazine hydrate afforded the corresponding 6 beta-amino derivatives.
• (+)-MORPHINANS AS ANTAGONISTS OF TOLL-LIKE RECEPTOR 9 AND THERAPEUTIC USES THEREOF
  申请人：Mallinckrodt LLC

  公开号：US20170029432A1

  公开（公告）日：2017-02-02

  The present invention provides (+)-morphinans comprising Toll-like receptor 9 (TLR9) antagonist activity, as well as methods for using the (+)-morphinans to treat pain. Also provided are pharmaceutical combination compositions comprising a (+)-morphinan and an opioid agonist/monoamine reuptake inhibitor, as well as methods for using the combination compositions to treat pain.
• US9562014B2
  申请人：——

  公开号：US9562014B2

  公开（公告）日：2017-02-07